| Browse |
| Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants. |
| Lineage (WHO label)   | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |
|---|---|---|---|---|---|---|---|---|---|---|
| B.1.1.53 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| BQ.1.30 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| CH.1.1.18 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| XBR | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| CH.1.1.30 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| BA.5.2.59 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| BQ.1.25.1 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| BQ.1.25 | S | Chan-S | CAAGCTATAACGCAGCCTGTA | 21 | 47.62 | 22869 | 22849 | R | -18625.1 | China |
| FU.2.1 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18622.3 | Singapore |
| B.1.264.1 | N | CN-CDC-N | GGGGAACTTCTCCTGCTAGAAT | 22 | 50 | 28881 | 28902 | F | -18617.7 | China |
| B.1.221.4 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.221.3 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.221.1 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.425 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| HG.1 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| JD.1.1 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| GK.1.4 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| XBB.2.3.9 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| FY.1.2.1 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| EG.1.5 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| C.31 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.221 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.221.2 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| B.1.343 | S | Young-S | ATCCAGCCTCTTATTATGTTAGAC | 24 | 37.5 | 21876 | 21853 | R | -18611 | Singapore |
| XBB.1.5 | E | Won-E | CACACAATCGATGCGCAGTA | 20 | 50 | 26365 | 26346 | R | -18609.9 | South Korea |
| BQ.1.1.70 | N | US-CDC-N-1 | GACCCCAAAATCAGCGAAAT | 20 | 45 | 28287 | 28306 | F | -18597.1 | US |
| AP.1 | N | US-CDC-N-1 | GACCCCAAAATCAGCGAAAT | 20 | 45 | 28287 | 28306 | F | -18597.1 | US |
| AJ.1 | N | US-CDC-N-3 | GGGAGCCTTGAATACACCAAAA | 22 | 45.45 | 28681 | 28702 | F | -18597 | US |
| KW.1 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| LG.1 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| KW.1.1 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| JN.1.28.1 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| JN.1.7.6 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| KW.1.1.1 | S | WuhanCoV-spk1 | TTGGCAAAATTCAAGACTCACTTT | 24 | 33.33 | 24354 | 24377 | F | -18584.5 | Japan |
| BA.5.2.20 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BQ.1.1 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| DV.3 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BA.4.1.8 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BN.1.3 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BA.5.1.22 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BA.2.75 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BA.5 (Omicron) | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BA.5.5 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| CH.1.1.2 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BE.1 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BR.1 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| CH.1.1.28 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BF.5 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| CH.1.1 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| BF.7.6 | ORF1ab | Pasteur-ORF1ab-2 | GGTAACTGGTATGATTTCG | 19 | 42.11 | 14080 | 14098 | F | -18581.4 | France |
| Lineage (WHO label) | Target Gene | Primer Name | Primer Sequence | Primer Length | Primer GC Content (%) | Start Position | End Position | Primer Direction | ΔG (cal) | Primer first used |